BridgeBio Pharma Inc. (BBIO) Misses Q2 EPS by 18c

BridgeBio Pharma Inc. (NASDAQ: BBIO) reported Q2 EPS of ($0.78), $0.18 worse than the analyst estimate of ($0.60). Revenue for the quarter came in at $243.67 million versus the consensus estimate of $220.19 million.

For earnings history and earnings-related data on BridgeBio Pharma Inc. (BBIO) click here.

You May Also Be Interested In

• Tesla readies August launch of CyberCab - The Information
• Sandisk (SNDK) call put ratio 1.1 calls to 1 put on active option volume of 300K contracts as share price up 7.5%
• RoundHill T-Rex 2X Long (RAM) call put ratio 2.7 calls to 1 put on active option volume of 23K contracts as share price up 9.8%